Suppression of cerebral hemodynamics is associated with reduced functional capacity in patients with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Fu, Tieh Cheng ^a   Wang, Chao Hung ^b   Hsu, Chih Chin ^a   Cherng, Wen Jin ^b   Huang, Shu Chun ^b   Wang, Jong Shyan ^c  

^a Department of Physical Medicine and Rehabilitation ^*  (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cardiac function; Perfusion; Ventilation

Indexed keywords

ADULT; ARTICLE; BICYCLE ERGOMETER; BRAIN BLOOD FLOW; BREATHING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; EXERCISE TEST; FEMALE; FRONTAL LOBE; FUNCTIONAL STATUS; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HUMAN; INFRARED SPECTROSCOPY; MAJOR CLINICAL STUDY; MALE; NEAR INFRARED SPECTROSCOPY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VASTUS LATERALIS MUSCLE;

AGED; CARBON DIOXIDE; CARDIAC OUTPUT; CEREBRAL CORTEX; COGNITION DISORDERS; EXERCISE; EXERCISE TEST; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; OXYGEN; OXYGEN CONSUMPTION; PULMONARY VENTILATION; REGIONAL BLOOD FLOW;

EID: 79955067104     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00867.2010     Document Type: Article

References (43)

1. Abete P, Napoli C, Santoro G, Ferrara N, Tritto I, Chiariello M, Rengo F, Ambrosio G. Age-related decrease in cardiac tolerance to oxidative stress. J Mol Cell Cardiol 31: 227-236, 1999.
2. Adachi H, Nguyen PH, Belardinelli R, Hunter D, Jung T, Wasserman K. Nitric oxide production during exercise in chronic heart failure. Am Heart J 134: 196-202, 1997.
3. Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation. Am J Physiol Regul Integr Comp Physiol 296: R1473-R1495, 2009.
4. Amann M, Eldridge MW, Lovering AT, Stickland MK, Pegelow DF, Dempsey JA. Arterial oxygenation influences central motor output and exercise performance via effects on peripheral locomotor muscle fatigue in humans. J Physiol 575: 937-952, 2006.
5. American College of Sports Medicine. General principle of exercise prescription. In: ACSM's Guidelines for Exercise Testing and Prescription, eighth ed., edited by WR Thompson, NF Gordon, LS Pescatello. Philadelphia, PA: Lippincott Williams & Wilkins, 2010, p. 152-182.
6. Arena R, Guazzi M, Myers J. Ventilatory abnormalities during exercise in heart failure: A mini review. Cur Respir Med Rev 3: 179-187, 2007.
7. Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 28: 1567-1572, 1996.
8. Buono MJ, Miller PW, Hom C, Pozos RS, Kolkhorst FW. Skin blood flow affects in vivo near-infrared spectroscopy measurements in human skeletal muscle. Jpn J Physiol 55: 241-244, 2005.
9. Cacciatore F, Abete P, Mazzella F, Viati L, Della Morte D, D'Ambrosio D, Gargiulo G, Testa G, Santis D, Galizia G, Ferrara N, Rengo F. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest 35: 723-30, 2005.
10. Crimi E, Ignarro LJ, Cacciatore F, Napoli C. Mechanisms by which exercise training benefits patients with heart failure. Nat Rev Cardiol 6: 292-300, 2009.
11. Davila DF, Nunez TJ, Odreman R, de Davila CAM. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Int J Cardiol 101: 343-346, 2005.
12. Dempsey JA, Amann M, Romer LM, Miller JD. Respiratory system determinants of peripheral fatigue and endurance performance. Med Sci Sports Exerc 40: 457-461, 2008.
13. Duncan A, Meek JH, Clemence M, Elwell CE, Tyszczuk L, Cope M, Delpy DT. Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy. Phys Med Biol 40: 295-304, 1995.
14. Ferrara N, Davia K, Abete P, Rengo F, Harding SE. Alterations in beta-adrenoceptor mechanisms in the aging heart. Relationship with heart failure. Aging (Milano) 9: 391-403, 1997.
15. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 47: 33-39, 1981.
16. Henson LC, Calalang C, Temp JA, Ward DS. Accuracy of a cerebral oximeter in healthy volunteers under conditions of isocapnic hypoxia. Anesthesiology 88: 58-65, 1998.
17. Immink RV, Secher NH, van Lieshout JJ. Cerebral autoregulation and CO2 responsiveness of the brain (Abstract). Am J Physiol Heart Circ Physiol 291: H2018, 2006.
18. Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol 293: H583-H589, 2007.
19. Koike A, Hoshimoto M, Nagayama O, Tajima A, Kubozono T, Oikawa K, Uejima T, Momose T, Aizawa T, Fu LT, Itoh H. Cerebral oxygenation during exercise and exercise recovery in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 94: 821-824, 2004.
20. Koike A, Itoh H, Oohara R, Hoshimoto M, Tajima A, Aizawa T, Fu LT. Cerebral oxygenation during exercise in cardiac patients. Chest 125: 182-190, 2004.
21. Lee CW, Lee JH, Kim JJ, Park SW, Hong MK, Kim ST, Lim TH, Park SJ. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 33: 1196-1202, 1999.
22. Lee CW, Lee JH, Lim TH, Yang HS, Hong MK, Song JK, Park SW, Park SJ, Kim JJ. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation 103: 2784-2787, 2001.
23. Maurer MM, Burkhoff D, Maybaum S, Franco V, Vittorio TJ, Williams P, White L, Kamalakkannan G, Myers J, Mancini DM. A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. J Card Fail 15: 689-699, 2009.
24. Myers J, Arena R, Oliveira RB, Bensimhon D, Hsu L, Chase P, Guazzi M, Brubaker P, Moore B, Kitzman D, Peberdy MA. The lowest VE/VCO2 ratio during exercise as a predictor of outcomes in patients with heart failure. J Card Fail 15: 756-762, 2009.
25. Myers J, Gujja P, Neelagaru S, Burkhoff D. Cardiac output and cardiopulmonary responses to exercise in heart failure: application of a new bio-reactance device. J Card Fail 13: 629-636, 2007.
26. Nybo L, Rasmussen P. Inadequate cerebral oxygen delivery and central fatigue during strenuous exercise. Exerc Sport Sci Rev 35: 110-118, 2007.
27. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL, HF ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301: 1439-1450, 2009.
28. Piepoli MF, Dimopoulos K, Concu A, Crisafulli A. Cardiovascular and ventilatory control during exercise in chronic heart failure: role of muscle reflexes. Int J Cardiol 130: 3-10, 2008.
29. Piña IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107: 1210-1225, 2003.
30. Ponikowski P, Banasiak W. Chemosensitivity in chronic heart failure. Heart Fail Monit 1: 126-131, 2001.
31. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, Poole-Wilson PA, Piepoli MF, Coats AJ. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104: 544-549, 2001.
32. Rasmussen P, Dawson EA, Nybo L, van Lieshout JJ, Secher NH, Gjedde A. Capillary-oxygenation-level-dependent near-infrared spectrometry in frontal lobe of humans. J Cereb Blood Flow Metab 27:1082-1093, 2007.
33. Remme WJ, Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527-1560, 2001.
34. Sperandio PA, Borghi-Silva A, Barroco A, Nery LE, Almeida DR, Neder JA. Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF. Am J Physiol Heart Circ Physiol 297: H1720-H1728, 2009.
35. Squara P, Denjean D, Estagnasie P, Brusset A, Dib JC, Dubois C. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med 33: 1191-1194, 2007.
36. Stickland MK, Miller JD, Smith CA, Dempsey JA. Carotid chemoreceptor modulation of regional blood flow distribution during exercise in health and chronic heart failure. Circ Res 100: 1371-1378, 2007.
37. Subudhi AW, Dimmen AC, Roach RC. Effects of acute hypoxia on cerebral and muscle oxygenation during incremental exercise. J Appl Physiol 103: 177-183, 2007.
38. Tran TK, Sailasuta N, Kreutzer U, Hurd R, Chung Y, Mole P, Kuno S, Jue T. Comparative analysis of NMR and NIRS measurements of intracellular PO2 in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 276: R1682-R1690, 1999.
39. van Beekvelt MC, Colier WN, Wevers RA, van Engelen BG. Performance of near-infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle. J Appl Physiol 90: 511-519, 2001.
40. van der Zee P, Cope M, Arridge SR, Essenpreis M, Potter LA, Edwards AD, Wyatt JS, McCormick DC, Roth SC, Reynolds EO, Delpy DT. Experimentally measured optical pathlengths for the adult head, calf and forearm and the head of the newborn infant as a function of inter optode spacing. Adv Exp Med Biol 316: 143-153, 1992.
41. Wang JS, Wu MH, Mao TY, Fu TC, Hsu CC. Effects of normoxic and hypoxic exercise regimens on cardiac, muscular, and cerebral hemodynamics suppressed by severe hypoxia in humans. J Appl Physiol 109: 219-229, 2010.
42. Wasserman AJ, Patterson JL Jr. The cerebral vascular response to reduction in arterial carbon dioxide tension. J Clin Invest 40: 1297-1303, 1961.
43. Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 127: 1637-1646, 2005.